title: Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients.
authors.forename: K K
authors.initials: KK
authors.lastname: Eklund
authors.forename: A
authors.initials: A
authors.lastname: Remitz
authors.forename: H
authors.initials: H
authors.lastname: Kautiainen
authors.forename: S
authors.initials: S
authors.lastname: Reitamo
authors.forename: M
authors.initials: M
authors.lastname: Leirisalo-Repo
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010865:Pilot Projects; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012720:Severity of Illness Index; D025241:Spondylarthritis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate